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Widespread application of next-generation sequencing
(NGS) is greatly expanding diagnostic options in preimplan-
tation genetic diagnosis (PGD). Yet paradoxically the en-
hanced beneﬁt of NGS with respect to its increased sensitivity
also raises clinical dilemmas encountered infrequently when
using less sensitive methods, for example ﬂuorescence in-
situ hybridization (FISH) or bacterial artiﬁcial chromosome
(BAC)-derived array comparative genomic hybridization
(CGH).
Given the increasing transition to NGS for diagnosis, it
seems timely to review the baseline on which we have been
operating prior to NGS. A good illustration of this is pro-
vided by Ravichandran et al., (2016) in this issue of RBM Online
in an article concerning sex chromosome misdiagnoses at
Reprogenetics between 2006 and 2013. The paper reports on
18,565 cycles subjected to cleavage stage (blastomere) biopsy
and 2791 subjected to blastocyst (trophectoderm) biopsy.
Results were mostly based on FISH with chromosome-speciﬁc
probes; 24-chromosome testing by array CGH was used less
often. Overall, there were 17 discrepancies in 7391 evaluable
cycles. In cleavage-stage embryos sex chromosome misdiag-
nosis occurred in 7/5855 (0.12%) with FISH, and 4/841 (0.48%)
with array CGH. In 10 of these 11 cases the explanation was
mosaicism; in one case dispermic fertilization. Although mis-
diagnosis in cleavage-stage embryos occurred using both array
CGH and FISH, in this sample no errors (0/695) were re-
corded using trophectoderm biopsies interrogated by array
CGH.
Will the misdiagnosis rate differ using NGS? Could it be less,
given NGS being more sensitive than FISH or the array CGH
employed during the 2006–2013 interval of study? Or, could
it be more if confounded by clinically inconsequential ﬁnd-
ings, perhaps the equivalent of variants of unknown signiﬁ-
cance detected by exome or genome sequencing. Of course,
the question needing greatest clarity will not involve sex chro-
mosomes but autosomes.
Available data using NGS-based PGD for aneuploidy (PGD-
A) indicate not infrequentmosaicism in tropectoderm biopsy.
Yet we have been down this path before. Cultured amniotic
ﬂuid cells unexpectedly showed mosaicism in early amniotic
ﬂuid cell cultures, usually without clinical signiﬁcance. Tet-
raploidy was also observed in clinically normal cases. The
nascent prenatal genetic diagnosis community did not react
with alarm, but generatedmeasured responses. Decades later
conﬁned placental mosaicism (CPM) was observed in 1–2% of
chorionic villi samples. Geneticists and clinicians soon devised
robustmanagement algorithms; again fewcases proved to have
clinical signiﬁcance. Chorionic villus sampling (CVS) experi-
ence with CPM is especially relevant to PGD because troph-
ectodermdevelops into placenta; thus,mosaicism in blastocyst
biopsy is not surprising. The only surprise may be the abso-
lute level of mosaicism in trophectoderm biopsy. Probably,
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this reﬂects in partmore cells/DNA and, hence, greater ability
to identify more than one cell line. However, diagnosis now
also utilizes or more sensitive NGS technology. Data pre-
sented at the 2016 PGDIS conference (Abstracts: 15th
International ConferenceonPreimplantationGeneticDiagnosis,
2016) showedmosaicism in 20–25% of human blastocysts sub-
jected to analysis on a validated NGS platform. Thus, a new
PGDIS Position Statement has beenprepared to facilitate dialog
and recommendations (http://www.pgdis.org/docs/newsletter
_071816.html).
This PGDIS Position Statement is reproduced on inside
backmatter cover of this issue. Comments are welcome.
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